Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection

被引:41
作者
Kim, JW
Namkoong, SE
Ryu, SW
Kim, HS
Shin, JW
Lee, JM
Kim, DH
Kim, IK
机构
[1] Catholic Univ, Coll Med, Kangnam St Marys Hosp, Dept Obstet & Gynecol,Seocho Ku, Seoul 137040, South Korea
[2] Catholic Univ, Coll Med, Catholic Res Inst Med Sci, Res Inst Mol Genet,Seocho Ku, Seoul 137040, South Korea
[3] Catholic Univ, Coll Med, Dept Biochem, Seocho Ku, Seoul 137040, South Korea
关键词
D O I
10.1006/gyno.1998.5041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Alterations of the p15(INK4B) and p16(INK4A) gene which are separated by 25 kb on chromosome 9p21 have been reported in various tumor-derived cell lines and primary tumors, but the role of these genes in cervical cancer is unknown, To determine the frequency of deletions and point mutations of these genes in human cervical cancer, we examined for alterations of the p15(INK4B) and p16(INK4A) genes in cervical carcinomas. Methods. We examined 57 primary tumors and matched normal tissues and 3 cervical cancer-derived cell lines. All the tumor tissues and cell lines were human papillomavirus (HPV) positive. Deletions or point mutations of exon 2 of the p(INK4B) gene and exons 1, 2, and 3 of the p16(INK3A) gene were examined by polymerase chain reaction and direct sequencing, respectively. Results. Our data indicate no evidence for intragenic homozygous deletion or point mutation in the primary cervical cancer tissues or cancer-derived cell lines. Conclusion, Deletions or point mutations in the p15(INK4B) Or p16(INK4A) gene may not be required for the development of HPV-positive cervical cancer or for establishment of cervical cancer cell lines. (C) 1998 Academic Press.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 32 条
  • [21] STRUCTURAL INTEGRITY OF THE CYCLIN-DEPENDENT KINASE INHIBITOR GENES, P15, P16 AND P18 IN MYELOID LEUKEMIAS
    NAKAWAKI, T
    KAWAMATA, N
    SCHWALLER, J
    TOBLER, A
    FEY, M
    PAKKALA, S
    LEE, YY
    KIM, BK
    FUKUCHI, K
    TSURUOKA, N
    KAHAN, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (01) : 139 - 149
  • [22] OHTA M, 1994, CANCER RES, V54, P5050
  • [23] OKAMOTO A, 1995, CANCER RES, V55, P1448
  • [24] Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, PRAD-1 and HPV
    Olshan, AF
    Weissler, MC
    Pei, H
    Conway, K
    Anderson, S
    Fried, DB
    Yarbrough, WG
    [J]. ONCOGENE, 1997, 14 (07) : 811 - 818
  • [25] TRANSFER OF A NORMAL HUMAN CHROMOSOME-11 SUPPRESSES TUMORIGENICITY OF SOME BUT NOT ALL TUMOR-CELL LINES
    OSHIMURA, M
    KUGOH, H
    KOI, M
    SHIMIZU, M
    YAMADA, H
    SATOH, H
    BARRETT, JC
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1990, 42 (03) : 135 - 142
  • [26] A NEW REGULATORY MOTIF IN CELL-CYCLE CONTROL CAUSING SPECIFIC-INHIBITION OF CYCLIN-D/CDK4
    SERRANO, M
    HANNON, GJ
    BEACH, D
    [J]. NATURE, 1993, 366 (6456) : 704 - 707
  • [27] G1 PHASE PROGRESSION - CYCLING ON CUE
    SHERR, CJ
    [J]. CELL, 1994, 79 (04) : 551 - 555
  • [28] TAM SW, 1994, ONCOGENE, V9, P2663
  • [29] WASHIMI O, 1995, CANCER RES, V55, P514
  • [30] p16(INK4) and p15(INK4B) alterations in primary gynecologic malignancy
    Wong, YF
    Chung, TKH
    Cheung, TH
    Nobori, T
    Yim, SF
    Lai, KWH
    Yu, AL
    Diccianni, MB
    Li, TZ
    Chang, AMZ
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 65 (02) : 319 - 324